Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) Tax Provisions (2016 - 2025)

Haemonetics (HAE) has 17 years of Tax Provisions data on record, last reported at $15.2 million in Q4 2025.

  • For Q4 2025, Tax Provisions rose 22.9% year-over-year to $15.2 million; the TTM value through Dec 2025 reached $51.7 million, up 49.2%, while the annual FY2025 figure was $44.4 million, 29.4% up from the prior year.
  • Tax Provisions reached $15.2 million in Q4 2025 per HAE's latest filing, up from $12.6 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $15.2 million in Q4 2025 and bottomed at -$16.4 million in Q2 2021.
  • Average Tax Provisions over 5 years is $7.4 million, with a median of $8.3 million recorded in 2022.
  • Peak YoY movement for Tax Provisions: crashed 478.09% in 2021, then soared 320.3% in 2025.
  • A 5-year view of Tax Provisions shows it stood at $5.1 million in 2021, then skyrocketed by 83.18% to $9.3 million in 2022, then surged by 37.93% to $12.8 million in 2023, then fell by 3.16% to $12.4 million in 2024, then grew by 22.9% to $15.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were $15.2 million in Q4 2025, $12.6 million in Q3 2025, and $11.1 million in Q2 2025.